{"nct_id":"NCT03249714","title":"Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2018-03-15","start_date_type":"ACTUAL","primary_completion_date":"2019-12-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}